News & Updates

A recent systematic review and meta-analysis has found that more than one in five patients develop postinfection irritable bowel syndrome (PI-IBS) following Clostridioides difficile infection (CDI).

The COVID-19 pandemic has contributed to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with irritable bowel syndrome (IBS) and comorbid anxiety and/or depression, reveals a study.

Patients with COVID-19 who received mechanical ventilation while admitted to the intensive care unit (ICU) have an elevated risk of invasive fungal infections (IFIs), according to results of the MYCOVID study from France. Furthermore, patients with COVID-19–associated pulmonary aspergillosis (CAPA) may be at an increased risk for death.

The implementation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic has significantly reduced the incidences of S. pneumoniae and Salmonella spp. among nine major pathogens of invasive bacterial infection (IBI) in children, reports a study.

The chances of hepatitis B surface antigen (HBsAg) loss after withdrawing nucleo(s)tide analogue (NUC) treatment depend on factors such as patient ethnicity, end-of-treatment antigen levels, and HBV genotype, a new study reports.

The use of face masks during the COVID-19 pandemic does not reduce compliance to social distancing or other public health control measures, a recent study has found.

Alcohol-based hand disinfectants might be insufficient to suppress hepatitis E virus infectivity, a new study has found.